|
|
CrossRef Text and Data Mining | |
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. | |
The role of p21/CIP1/WAF1 (p21) in the negative regulation of the growth hormone/growth hormone receptor and epidermal growth factor/epidermal growth factor receptor pathways, in growth hormone transduction defect | |
Eirini Kostopoulou, Andrea Paola Rojas Gil, Bessie E. Spiliotis | |
Ann Pediatr Endocrinol Metab. 2018;23(4):204-209. Published online December 31, 2018 DOI: https://doi.org/10.6065/apem.2018.23.4.204 |
|
The role of p21/CIP1/WAF1 (p21) in the negative regulation of the growth hormone/growth hormone receptor and epidermal growth factor/epidermal growth factor receptor pathways, in growth hormone transduction defect Mapping the Human Growth Hormone-Releasing Hormone Receptor (GHRHR) Gene to the Short Arm of Chromosome 7 (7p13-p21) near the Epidermal Growth Factor Receptor (EGFR) Gene Epidermal growth factor receptor levels increase but epidermal growth factor receptor ligand levels decrease in mouse mammary tumors during progression from hormone dependence to hormone independence Epidermal Growth Factor Receptors and Receptor Localization in Thyroid Follicle Cells The role of growth hormone and insulin-like growth factor I in the regulation of apoptosis Insulin-like growth factor I receptor regulation in prostate carcinoma Regulation of proliferation and apoptosis by the insulin-like growth factor I receptor Negative Regulation of Hypothalamic Growth Hormone-Releasing Factor Messenger Ribonucleic Acid by Growth Hormone and Insulin-Like Growth Factor I The role of the insulin-like growth factor-I receptor in malignancy: An update Delaying Chemotherapy in the Treatment of Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer |